Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-02-25 @ 8:15 PM
Study NCT ID:
NCT03911557
Status:
COMPLETED
Last Update Posted:
2025-11-12
First Post:
2019-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
Sponsor:
John L. Villano, MD, PhD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MCC-18-MULTI-25-PMC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None